Metrics as of 10/16/2026, 08:50 AM (Berlin time), refresh in progress.
iTonic Holdings Stock
iTonic Holdings Ltd.
Company data
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Country
- China
- CEO
- Jianfei Zhang
- Employees
- 7
- Market cap
- $26 M
- IPO
- 05/09/2024
iTonic Holdings Ltd., a healthcare solutions firm, specializes in the development and commercialization of software and devices for brachytherapy. Its advanced proprietary treatment planning system centers on radioactive particle implantation, a form of radiotherapy employed in cancer treatment to precisely position…
iTonic Holdings stock: price history
1D
-3.7%
1W
-5.2%
1M
-20.2%
6M
-24.0%
YTD
-42.7%
1Y
–
2Y
–
5Y
–
10Y
–
Ask the agents about iTonic Holdings
iTonic Holdings stock metrics
P/E
-0.92
P/B
0.73
EV/EBITDA
-3.22
RETURN ON EQUITY
-24.8%
NET MARGIN
-5,802.8%
DEBT/EQUITY
0.01
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
88.3%
FLOAT SHARES
6,038,406
AVG. DAILY VOLUME (30D)
51,572
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about iTonic Holdings stock
What does iTonic Holdings do?
iTonic Holdings Ltd. is a company in the Healthcare sector, Medical - Specialties industry, headquartered in China.
The CEO is Jianfei Zhang, the company employs around 7 people.
The IPO was on 05/09/2024; the stock trades on NASDAQ under the ticker ITOC.
Does iTonic Holdings pay a dividend?
No, iTonic Holdings currently does not pay a dividend.
Which stocks are comparable to iTonic Holdings?
Comparable stocks include STERIS, QuidelOrtho, Mesa Laboratories, 908 Devices, Trinity Biotech, Eli Lilly and Company, Johnson & Johnson and AbbVie.
How can I get iTonic Holdings stock analyzed?
Clicking "Analyze stock" lets five strategies assess iTonic Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.